Drugs Habits and Social Policy is an esteemed academic journal published by Emerald Group Publishing Ltd that focuses on the intersection of drug habits and the evolving landscape of social policy. With an ISSN of 2752-6739 and E-ISSN of 2752-6747, this journal contributes significantly to the fields of Clinical Psychology, Health Policy, and Public Health, and is ranked in the Q3 category across multiple disciplines in the 2023 categorizations. Featuring research that spans from 2022 to 2024, the journal provides a platform for critical insights and evidence-based discussions that are essential for understanding the social implications of drug use. Despite its current quartile ranking, the journal aims to elevate discourse among researchers, professionals, and students alike, reinforcing its commitment to impactful scholarship that can inform policy and practice. The journal is based in the United Kingdom, with its operations housed at Floor 5, Northspring 21-23 Wellington Street, Leeds, W YORKSHIRE LS1 4DL, ENGLAND. As a pivotal resource in its field, Drugs Habits and Social Policy invites contributions that can shape the future of health policy and improve societal outcomes.

JOURNAL OF PSYCHOACTIVE DRUGS, published by Routledge Journals, Taylor & Francis Ltd, stands as a leading resource in the fields of psychology and medicine, focusing on the intersection of psychoactive substances and their impact on human behavior. With an ISSN of 0279-1072 and E-ISSN 2159-9777, this esteemed journal has been a pivotal platform for rigorous research since its inception in 1967, contributing to the understanding of drug use, its societal implications, and therapeutic potentials. It currently holds a Q2 ranking in both the miscellaneous categories of Medicine and Psychology for 2023, reflecting its significant standing within academic circles. Moreover, its Scopus rankings place it at the 49th percentile in General Psychology and 101st in Medicine, underscoring its relevance in contemporary research. Although it is not available via Open Access, the journal maintains a commitment to advancing knowledge through its annual publications until 2024. JOURNAL OF PSYCHOACTIVE DRUGS is essential for researchers, professionals, and students seeking to explore the complexities of psychoactive substances and their effects in various contexts.

SUBSTANCE USE & MISUSE, published by Taylor & Francis Inc, is an esteemed academic journal dedicated to the multifaceted study of substance use and its implications on health and society. With a notable impact factor and categorized in the Q2 quartile across multiple fields—including Health (Social Science), Medicine (Miscellaneous), Psychiatry and Mental Health, as well as Public Health—this journal serves as an essential platform for researchers, professionals, and students alike. Spanning from 1966 to 2024, it provides a rich archive of peer-reviewed articles that explore current trends, innovative research, and evidence-based practices in the management and understanding of substance use. The journal offers various access options, catering to the diverse needs of its audience and affirming its commitment to fostering scholarly discourse in the United Kingdom and beyond. By engaging with this journal, readers can enhance their understanding of the complexities surrounding substance use, making it a crucial resource for advancing knowledge and informing policy in this critical area of public health.

Adicciones is a prominent academic journal dedicated to the fields of Medicine and Psychiatry, focusing on the multi-faceted issues surrounding addiction and substance use. Published by SOCIDROGALCOHOL in Spain, this journal has been a critical resource for researchers, clinicians, and students since its inception in 1994, with a commitment to advancing knowledge in addiction science for the benefit of public health. With an impressive impact factor that places it in the Q3 category of both Medicine (Miscellaneous) and Psychiatry and Mental Health according to 2023 rankings, Adicciones is recognized for its high-quality peer-reviewed articles that contribute to the ongoing dialogue in these vital fields. Although not currently an open-access journal, it provides valuable subscription-based access to its extensive repository of research findings and reviews, fostering a deeper understanding of the complex dynamics of addiction. The journal's continued relevance is underscored by its convergence into 2024, promising ongoing contributions that inspire new ideas and practices to combat addiction.

The Journal of Social Work Practice in the Addictions is a pivotal publication in the field of social work, dedicated to addressing the multifaceted challenges of addiction through rigorous research and practice. Published by Routledge Journals, Taylor & Francis Ltd, this journal has been a valuable resource since its inception in 2001 and continues to provide vital insights as it converges towards 2024. With a focus on empirical studies, theoretical advancements, and innovative practice approaches, it serves professionals and researchers alike who are engaged in the health and social sciences. Holding a respectable Q3 quartile ranking in both Health (Social Science) and Rehabilitation and a Q4 ranking in Social Work, it emphasizes the importance of interdisciplinary collaboration in tackling issues of addiction. The journal does not currently offer open access, ensuring exclusive dissemination to its dedicated readership, which includes practitioners, scholars, and students committed to improving outcomes for individuals affected by substance use disorders. As an essential platform within the community, it fosters knowledge exchange and supports evidence-based practice, thereby enhancing the field’s collective understanding of addiction-related challenges.

CONTEMPORARY DRUG PROBLEMS is a distinguished academic journal published by SAGE PUBLICATIONS INC, focusing on critical issues within the realms of drug policy, health advocacy, and law. With a legacy dating back to its inception in 1973 and a noticeable convergence in subsequent years, the journal serves as a vital forum for researchers, practitioners, and policymakers engaged in understanding the multifaceted challenges related to drug use and its societal impacts. Holding an impressive Q2 ranking in both Health Policy and Health (social science), and a Q1 distinction in Law, the journal positions itself as an essential resource for advancing knowledge and fostering dialogue in these essential fields. Although it operates under traditional access models, its wide-ranging insights make it indispensable for those who aim to contribute meaningfully to the discourse surrounding contemporary drug issues. With its robust Scopus rankings, including a significant 89th percentile in Social Sciences Law, CONTEMPORARY DRUG PROBLEMS remains a pivotal source for scholars and professionals alike, striving to address and mitigate the complexities of drug-related problems on both a legal and social front.

The AMERICAN JOURNAL ON ADDICTIONS, published by WILEY, stands as a premier publication within the realms of Clinical Psychology, Medicine, and Psychiatry. With its ISSN 1055-0496 and E-ISSN 1521-0391, the journal has been a critical resource since its inception in 1992, consistently evolving to encompass a wide scope of addiction research and its implications on public health. Renowned for its rigorous peer-reviewed articles, it boasts impressive rankings, including Q1 status in both Clinical Psychology and Medicine (miscellaneous) for 2023, and a respectable Q2 in Psychiatry and Mental Health. As a foundational platform for disseminating cutting-edge research, the journal aims to facilitate the exchange of knowledge among researchers, healthcare professionals, and educators alike. Its significant impact on the academic community is underscored by its Scopus rankings—placing it in the top 26% of Clinical Psychology journals and the top 28% in Medicine (miscellaneous). By fostering an understanding of addiction and its treatments, the AMERICAN JOURNAL ON ADDICTIONS plays an essential role in guiding innovative practices and shaping future policies within the field.

Drug and Alcohol Dependence is a premier journal published by Elsevier Ireland Ltd, dedicated to the rigorous exploration and analysis of substance use disorders, including drug and alcohol dependencies. With its established history since 1975 and a remarkable convergence of research extending to 2024, the journal holds a prestigious position within the academic community, evidenced by its Q1 ranking in multiple categories, including Pharmacology, Psychiatry and Mental Health, and Toxicology for 2023. It ranks impressively among its peers, underscored by Scopus rankings of #46, #99, and #27 in key fields related to medical pharmacology and toxicology. As a non-open access title, it caters to a global readership of researchers, professionals, and students, providing them with peer-reviewed insights into critical developments and innovative methodologies in the field. The journal’s commitment to advancing knowledge and understanding of drug and alcohol dependence is essential for addressing the global challenges posed by substance use, making it a valuable resource for all stakeholders in public health and clinical practice.

Substance Abuse Treatment, Prevention, and Policy is a premier open access journal published by BMC, dedicated to advancing the understanding and improvement of substance abuse treatment and prevention strategies. Since its inception in 2006, this journal has established itself as a significant resource in the fields of Health Policy and Psychiatry and Mental Health, proudly maintaining a strong reputation reflected in its 2023 Scopus rankings, which place it in the top quartiles of these categories. With an impactful focus on policy implications and evidence-based practices, the journal's comprehensive coverage supports the sharing of innovative research and perspectives aimed at mitigating substance abuse challenges worldwide. Open access since its launch, it ensures that vital research is readily available to researchers, practitioners, and students alike, facilitating collaboration and discourse in this critical area of public health. Its commitment to high-quality research is underscored by its rankings within the 78th percentile for Health Policy and 66th percentile for Psychiatry and Mental Health, highlighting its influence and relevance in addressing pressing issues in substance misuse.

Suchttherapie, an esteemed journal published by GEORG THIEME VERLAG KG, serves as a critical platform within the fields of Applied Psychology and Psychiatry and Mental Health. Established in 2000 and continuing through 2024, this journal is committed to advancing the understanding and treatment of addiction and related psychological issues. Although it currently stands in the Q4 Quartile ranking and is categorized as low percentile in both Scopus Ranks and impact metrics, its significance lies in its dedication to disseminating cutting-edge research and clinical findings that contribute to the evolving landscape of therapeutic practices. Published in Germany, the journal facilitates unlimited access to the vital discourse surrounding mental health and addiction treatment, making it a valuable resource for researchers, professionals, and students alike seeking to enhance their knowledge and skills in this important area of study. As the field continues to grow, Suchttherapie plays a pivotal role in bridging practice with academic rigor, ensuring that readers remain informed on the latest methodologies and insights.